ArticleOncotarget2017

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients.

Lauren Averett Byers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.